Lara Donovan
About Lara Donovan
Lara Donovan is the Associate Director of Market Access at Bristol Myers Squibb in Melbourne, Victoria, Australia, with over a decade of experience in the pharmaceutical industry focusing on market access and health economics.
Company
Lara Donovan is currently associated with Bristol Myers Squibb, where she holds the role of Associate Director, Market Access. She operates out of Melbourne, Victoria, Australia. Her tenure at Bristol Myers Squibb has been extensive, giving her a deep understanding of the company's market dynamics and strategic initiatives.
Title
As Associate Director, Market Access, Lara Donovan plays a crucial role in shaping and implementing strategies that enhance the availability and accessibility of pharmaceutical products. Her position requires a detailed understanding of health economics and market conditions within the pharmaceutical industry.
Professional Background at Bristol Myers Squibb
Lara Donovan has a rich history with Bristol Myers Squibb, having held multiple roles over the years. She began as a Health Economics Associate from 2010 to 2013, moved on to the position of Market Access Manager from 2013 to 2021, and transitioned to her current role as Associate Director, Market Access in November 2021. Her career at Bristol Myers Squibb spans over a decade, reflecting her deep-rooted expertise and commitment to the organization.
Previous Experience
Before her extensive career at Bristol Myers Squibb, Lara Donovan worked as a Research Fellow at Monash University - Centre for Health Economics from 2007 to 2010. Her role involved contributing to academic research in health economics, which provided her with significant insights into the economic aspects of healthcare.
Education and Expertise
Lara Donovan's educational background is comprehensive, with degrees in both pharmacy and economics. She earned a Bachelor of Pharmacy (BPharm) from Monash University from 2000 to 2004, followed by a Bachelor of Commerce (BCom) from 2005 to 2007. She further pursued Economics (Honours) at Monash University in 2008. Her dual expertise in clinical pharmacy and economics equips her with a unique perspective, blending clinical and economic insights.